Trader Note — 2287 total
Palantir Technologies reports Q1 results on May 4 with a fresh analyst downgrade on the tape, shorts quietly building, and a stock sitting nearly flat on the week despite a sharp single-day bounce. The most pointed…
WTO heads into the first week of May having shed a third of its value in five days — with a dilutive capital raise announced on May 1 delivering the final blow to a stock already under heavy pressure. The catalyst is…
ALTG enters its May 7 Q1 2026 results carrying the most unusual setup the stock has seen in years — a near-50% rally in a single month, a freshly filed $300M shelf registration, and options traders positioned for…
TELA Bio enters its Q1 2026 earnings call with an unusually charged setup: a near-50% weekly price surge, a preliminary revenue beat, and a sweeping board refresh — all landing in the same week. The catalyst is clear.…
Custom Truck One Source heads into the first week of May having done something almost no stock in its peer group managed this month: rally more than 50%. The price move is the story. CTOS closed at $10.10 on May 1, up…
CUE just had its biggest week in recent memory — and the catalyst wasn't a trial readout. The small-cap biotech announced a $30 million private placement, licensed a clinical-stage dual-mechanism anti-IgE antibody…
CELC enters its most consequential stretch in years with a Phase 3 trial win in hand — and roughly 29% of its float still short. The news broke after market close on May 1. Celcuity announced that its VIKTORIA-1 trial…
Four Corners Property Trust heads into the first week of May with a notable divergence: the CEO has been accumulating stock at current prices while short sellers, after a sharp retreat last month, are edging back…
AIOS Tech enters May in one of the most charged setups on Nasdaq — a stock that has more than doubled in a week, carries triple-digit borrow costs, and faces an earnings event in four days. The price action alone…
AUID heads into early May with an awkward juxtaposition: a fresh equity-diluting bridge loan announced mid-week, a stock that has shed 10% over the past month, and short sellers quietly retreating from a position they…
Upland Software enters May with its stock sitting near all-time lows and shorts quietly rebuilding — even as the broader lending market remains wide open. The most striking feature of the past week is how shorts have…
SCYX enters its May 6 earnings report carrying two notable developments: a 51% surge in short interest over the past week and a freshly filed S-3 shelf registration for 87 million shares by selling stockholders. Short…
BTCS Inc. heads into its May 13 earnings report carrying an unusual split: the stock has rallied hard while a meaningful short position refuses to budge. The price move has been striking. BTCS closed at $2.16 on May 1,…
BIVI heads into its most critical near-term catalyst — topline Phase 2 data for bezisterim in Parkinson's disease — having gained 12% on the week and 20% over the past month, closing at $1.68. The stock's move is being…
Antero Resources heads into its June 3 earnings date with a striking divergence: options traders are the most defensive they've been all year, even as short sellers quietly pull back. Options positioning tells the most…
DSS, Inc. enters the week before its May 15 earnings with one of the sharpest short-interest buildups seen among micro-cap industrials this spring — short positions more than tripled in under two weeks, right as the…
Caesarstone enters its May 6 Q1 2026 results with one of the clearest short-covering moves of recent weeks — and options traders still skewed heavily toward calls. Short interest has collapsed over the past month,…
XMax Inc. heads into its May 14 earnings date carrying two very different stories: a sharp short-seller retreat over the past week and a flurry of AI-deal announcements that have pushed the stock up 11% since last…
Birchtech Corp. heads into its May 13 Q1 earnings call with short sellers rebuilding positions at an extraordinary pace — against a backdrop of thin float and a CEO who recently bought in at a premium. The most…
InspireMD arrives at its May 4 earnings call having shed nearly 30% in a month, yet options positioning tells a sharply different story — one of unusual bullish conviction at the lows. The most striking signal this…
